Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 346 AL 360

Natural products as a rich source of tau-targeting drugs for Alzheimer's disease

Calcul L, Zhang B, Jinwal UK, Dickey CA, Baker BJ.

Future Med Chem. 2012 Sep;4(13):1751-61. doi: 10.4155/fmc.12.124.

BACE1 in Alzheimer's disease

Sathya M, Premkumar P, Karthick C, Moorthi P, Jayachandran KS, Anusuyadevi M.

Clin Chim Acta. 2012 Dec 24;414:171-8. doi: 10.1016/j.cca.2012.08.013. Epub 2012 Aug 20.

[Nutritional factors in prevention of Alzheimer's disease]

Wyka J.

Rocz Panstw Zakl Hig. 2012;63(2):135-40.

Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease

Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J.

Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):421-32. doi: 10.1177/1533317512454708.

Lifelong management of amyloid-beta metabolism to prevent Alzheimer's disease

Gandy S.

N Engl J Med. 2012 Aug 30;367(9):864-6. doi: 10.1056/NEJMe1207995.

Mixed dementia in clinical trials of Alzheimer's disease

Massoud F.

Can J Neurol Sci. 2012 Sep;39(5):566-7. doi: 10.1017/s0317167100015250.

P300 latency and amplitude in Alzheimer's disease: a systematic review

Pedroso RV, Fraga FJ, Corazza DI, Andreatto CA, Coelho FG, Costa JL, Santos-Galduróz RF.

Braz J Otorhinolaryngol. 2012 Jul-Aug;78(4):126-32. doi: 10.1590/S1808-86942012000400023.

Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis

Cattaneo A, Calissano P.

Mol Neurobiol. 2012 Dec;46(3):588-604. doi: 10.1007/s12035-012-8310-9. Epub 2012 Sep 1.

Processive proteolysis by γ-secretase and the mechanism of Alzheimer's disease

Wolfe MS.

Biol Chem. 2012 Sep;393(9):899-905. doi: 10.1515/hsz-2012-0140.

The immunopathogenic role of reactive oxygen species in Alzheimer disease

Mohsenzadegan M, Mirshafiey A.

Iran J Allergy Asthma Immunol. 2012 Sep;11(3):203-16.

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Jack CR Jr, Josephs KA.

Lancet Neurol. 2012 Oct;11(10):868-77. doi: 10.1016/S1474-4422(12)70200-4. Epub 2012 Sep 3.

Treatment strategies targeting amyloid β-protein

Schenk D, Basi GS, Pangalos MN.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006387. doi: 10.1101/cshperspect.a006387.

Decoding the non-coding RNAs in Alzheimer's disease

Schonrock N, Götz J.

Cell Mol Life Sci. 2012 Nov;69(21):3543-59. doi: 10.1007/s00018-012-1125-z. Epub 2012 Sep 6.

Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats

Mahdy K, Shaker O, Wafay H, Nassar Y, Hassan H, Hussein A.

Eur Rev Med Pharmacol Sci. 2012 Jul;16 Suppl 3:31-42.

Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's disease

Shen Q, Zhao W, Loewenstein DA, Potter E, Greig MT, Raj A, Barker W, Potter H, Duara R.

Alzheimers Dement. 2012 Sep;8(5):399-406. doi: 10.1016/j.jalz.2011.07.002.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias